Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D R Webb

Showing results (171-180 of 180) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 180 results.
International Immunology|August 1, 1995
Characterization of the epitope recognized by a mAb that reacts differentially with murine suppressor T cellsJ A Kapp, C W Pierce, D R Webb, et al.
British Journal of Urology|October 1, 1988
1500 cases of renal and ureteric calculi treated in an integrated stone centreG Das, J Dick, M J Bailey, et al.
Endocrine Connections|November 27, 2018
Moderate increases in daily step count are associated with reduced IL6 and CRP in women with PCOSM A Webb, H Mani, S J Robertson, et al.
Diabetes/Metabolism Research and Reviews|December 29, 2016
Cardiovascular risk factors and incident albuminuria in screen-detected type 2 diabetesD R Webb, F Zaccardi, M J Davies, et al.
Diabetologia|June 4, 2011
Screening for diabetes using an oral glucose tolerance test within a western multi-ethnic population identifies modifiable cardiovascular risk: the ADDITION-Leicester studyD R Webb, L J Gray, K Khunti, et al.
Trials|February 23, 2010
Rationale and design of the ADDITION-Leicester study, a systematic screening programme and randomised controlled trial of multi-factorial cardiovascular risk intervention in people with type 2 diabetes mellitus detected by screeningD R Webb, K Khunti, B Srinivasan, et al.
The Journal of Allergy and Clinical Immunology|February 9, 1999
Fluticasone propionate powder: oral corticosteroid-sparing effect and improved lung function and quality of life in patients with severe chronic asthmaH S Nelson, W W Busse, B P deBoisblanc, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|June 13, 2020
Patient-reported outcomes after 10-year follow-up of intensive, multifactorial treatment in individuals with screen-detected type 2 diabetes: the ADDITION-Europe trialE-M Dalsgaard, A Sandbaek, S J Griffin, et al.
Bioorganic & Medicinal Chemistry Letters|September 7, 1999
Selective A1-adenosine receptor antagonists identified using yeast Saccharomyces cerevisiae functional assaysR M Campbell, C Cartwright, W Chen, et al.
The Journal of Allergy and Clinical Immunology|November 18, 2000
Inhaled mometasone furoate reduces oral prednisone requirements while improving respiratory function and health-related quality of life in patients with severe persistent asthmaJ E Fish, J P Karpel, T J Craig, et al.
Pageof 18

Showing results (171-180 of 180) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 180 results.
International Immunology|August 1, 1995
Characterization of the epitope recognized by a mAb that reacts differentially with murine suppressor T cellsJ A Kapp, C W Pierce, D R Webb, et al.
British Journal of Urology|October 1, 1988
1500 cases of renal and ureteric calculi treated in an integrated stone centreG Das, J Dick, M J Bailey, et al.
Endocrine Connections|November 27, 2018
Moderate increases in daily step count are associated with reduced IL6 and CRP in women with PCOSM A Webb, H Mani, S J Robertson, et al.
Diabetes/Metabolism Research and Reviews|December 29, 2016
Cardiovascular risk factors and incident albuminuria in screen-detected type 2 diabetesD R Webb, F Zaccardi, M J Davies, et al.
Diabetologia|June 4, 2011
Screening for diabetes using an oral glucose tolerance test within a western multi-ethnic population identifies modifiable cardiovascular risk: the ADDITION-Leicester studyD R Webb, L J Gray, K Khunti, et al.
Trials|February 23, 2010
Rationale and design of the ADDITION-Leicester study, a systematic screening programme and randomised controlled trial of multi-factorial cardiovascular risk intervention in people with type 2 diabetes mellitus detected by screeningD R Webb, K Khunti, B Srinivasan, et al.
The Journal of Allergy and Clinical Immunology|February 9, 1999
Fluticasone propionate powder: oral corticosteroid-sparing effect and improved lung function and quality of life in patients with severe chronic asthmaH S Nelson, W W Busse, B P deBoisblanc, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|June 13, 2020
Patient-reported outcomes after 10-year follow-up of intensive, multifactorial treatment in individuals with screen-detected type 2 diabetes: the ADDITION-Europe trialE-M Dalsgaard, A Sandbaek, S J Griffin, et al.
Bioorganic & Medicinal Chemistry Letters|September 7, 1999
Selective A1-adenosine receptor antagonists identified using yeast Saccharomyces cerevisiae functional assaysR M Campbell, C Cartwright, W Chen, et al.
The Journal of Allergy and Clinical Immunology|November 18, 2000
Inhaled mometasone furoate reduces oral prednisone requirements while improving respiratory function and health-related quality of life in patients with severe persistent asthmaJ E Fish, J P Karpel, T J Craig, et al.
Pageof 18